South Africa Trailing behind South Africa’s pharmaceutical market in both value and growth, the nation’s medical device industry has long enjoyed minimal barriers to entry and easy market access. But, with imminent onset of a new regulatory regime, both local and multinational players of all sizes may have to start imposing stricter…

Pharma The traditional model of healthcare has generally been limited to treatment in health facilities. But, when it comes to effectively treating more private and deeply personal health conditions, especially in South Africa, companies such as Coloplast have untaken substantial efforts to partner hand-in-hand with patients through support programs that focus…

Pharma Eclectic demographics, rapid patient recruitment, and a burgeoning population with a gradient of disease profiles—these seem to be the fundamentals truly driving growth in South Africa’s clinical trial industry. However, without the presence of proper mechanisms to arbitrate between regulators and researchers, the sustained growth of this industry may very…

Pharma While South Africa faces a distinct set of challenges in effectively managing its healthcare sector, the ecosystem for innovation, particularly in the world of biotechnology remains fruitful. Bioentrepreneur Nick Duneas has taken the initiative to create his own startup and introduce the world’s first regenerating injectable bone-graph substitute into the…

Pharma In an exclusive discussion with Focus Reports, Egyptian Minister of Health, Dr. Ahmed El Din Rady sets out his blueprint for improving the nation’s welfare and securing positive public health outcomes with a 4-point plan based on human capital development, accessibility, countering hepatitis C, and large-scale infrastructural intervention. My foremost…

Pharma The Mauritian Government’s “Vision 2030” plan aims to transform the country into a high-income economy by 2030. The Healthcare and Life Science sector will play a key role in this transformation. Objective: To put Mauritius into the league of high-income economies Key focus areas: Address unemployment Alleviate, if not eradicate, poverty Open up…

Pharma Looking for the right conditions to operate, an increasing number of foreign companies within the life sciences sector are looking at Mauritius as the ideal location to establish their headquarters. Samer Kassem, CEO of Aspen Global Incorporated, and Miroslav Secerov, vice president of sales and marketing at NATEC Medical, talk…

Pharma Pharmaceuticals Mauritius’s economic stability, genetic diversity, cost competitiveness, and location make it a perfect location for clinical research; a fact the state is now actively promoting. A further vision of the Mauritian government is to transform the island into a medical hub for clinical research. Besides political and economic stability, a number of…

Pharma Below is a list of the Top 100 Pharma Companies in Turkey sorted by the total value of sales in USD for 2014. Global giant Novartis is number one in a market worth a total of more than seven billion dollars. Source: IMS Health Click here to read more articles and…

Despite a current lack of investment incentives; Turkey’s geographical location, market size, large and aging population, universal healthcare, potential future spending, and stage of economic development mean that it is already an immensely attractive destination for international pharma investors and will continue to be so for the foreseeable future. “Turkey…

Although the Turkish pharmaceutical market has grown significantly in recent years R&D investment remains comparatively low. However, the expertise and capabilities exist for growth in this sector. Turkish companies and international affiliates are also beginning to innovate, especially in combination products for which there is high demand. Multinational R&D investment…

Turkey In the first fifteen years of the 21st century Turkey saw rapid economic growth, greater access to healthcare, and a boom in pharmaceutical sales. The country’s healthcare sector is now entering a new era of greater govt support for the pharmaceutical industry, more focus on R&D and the potential for…